Delivery Order SPE2DB20D2104-SPE2DB23FQ76Z
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,834.45 firm fixed price delivery order is for the supply of 4563249507 - ESOMEPRAZOLE MAG DR 40 MG CAP 1000S, with a period of performance through January 8, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $2,874.31, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of ESOMEPRAZOLE MAG DR 40 MG CAP 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 25, 2024. The contract was awarded on November 22, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,319.56, is for the delivery of esomeprazole delayed-release packets in support of federal healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Esomeprazole DR 5 mg packets. The contract has a firm fixed-price, non-set-aside designation, and a ceiling value of $3,460.60. The period of performance extends through June 13, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables...
- This federal contract award is for the delivery of Esomeprazole Magnesium Delayed-Release capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $1,696.24. The contract is a delivery order with a firm fixed price type and has an ultimate completion date of February 28, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the supply of esomeprazole magnesium delayed-release (DR) capsules to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The firm-fixed-price delivery order, valued at $1,030.56, has an ultimate completion date of August 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,545.74 for the supply of esomeprazole magnesium delayed-release capsules. The contract was awarded by the Defense Logistics Agency (DLA) on February 6, 2023, with a completion date of February 7, 2023. The award is not designated as a set-aside contract. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,753.65 firm fixed-price delivery order covers the supply of 4,565,078,957 units of Esomeprazole Magnesium delayed-release 40 mg capsules. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award, SPE2DB22D3004|SPE2DB24FPJ47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,689.40 firm fixed-price delivery order is for the supply of 4,563,691,603 units of Esomeprazole Magnesium Delayed-Release 40mg Capsules. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,490.33, is for the delivery of 4,567,636,068 units of esomeprazole delayed-release capsules. The contract has a completion date of April 16, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FQ76ZDelivery Order
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB23FQ76Z, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,826.69 Delivery Order is for the supply of 4558809522 - ESOMEPRAZOLE MAG DR 20 MG CAP 90S, with an ultimate completion date of October 19, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 10/18/22 |